Create an Account
  1. Home
  2. Specialty
  3. Cataract & Refractive

Neurotrophic Keratitis: Improving Knowledge and Exploring Treatments

Neurotrophic Keratitis Improving Knowledge and Exploring Treatments
Media formats available:
Details
Presenters

  • Overview

    Neurotrophic keratitis is a rare, degenerative corneal disease characterized by decreased or absent corneal sensation, which can lead to epithelial breakdown, impairment of healing, and ultimately to the development of corneal ulceration, melting and perforation.

    Drs. Francis Mah (program chair), Marjan Farid and Sumitra Khandelwal, and Elizabeth Yeu, MD provide an engaging presentation on the diagnosis and stages of neurotrophic keratitis, available treatments, and potential anatomic outcomes. This on-demand webinar includes case discussions followed by an audience question-and-answer session from the live event.

    Supported by an independent medical education grant from Dompé.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Identify the stages of neurotrophic keratitis
    • Recognize how to differentiate neurotrophic keratitis from similar diseases
    • Describe the mechanisms of action of newer treatments and when they should be introduced into treatment regimens for neurotrophic keratitis, including the stepwise approach
    • Explain the relationships between disease characteristics, drug therapies, treatment frequency, visual, and anatomic outcomes

    • Accreditation

      This educational activity is provided by Evolve Medical Education LLC (Evolve).
       

      Accreditation Statement
      Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

      Credit Designation Statement
      Evolve designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
       

      Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.

       

       

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Francis S. Mah, MD

      Francis S. Mah, MD

      Director of Corneal and External Disease
      Co-Director of Refractive Surgery
      Scripps Clinic

      La Jolla, CA
       


      Sumitra Khandelwal, MD

      Sumitra Khandelwal, MD

      Associate Professor
      Medical Director – Lions Eye Bank of Texas
      Cornea, Cataract, and Refractive Surgery
      Baylor College of Medicine
      Houston, TX


      Marjan Farid, MD

      Marjan Farid, MD

      Director of Cornea, Cataract, and Refractive Surgery
      Vice Chair of Ophthalmic Faculty
      Clinical Professor of Ophthalmology
      Gavin Herbert Eye Institute
      University of California, Irvine
      Irvine, California


      Elizabeth Yeu, MD

      Elizabeth Yeu, MD

      Virginia Eye Consultants
      Medical Director, CVP Mid-Atlantic
      Cornea, Cataract, External Disease, and Refractive Surgery
      Assistant Professor, Department of Ophthalmology
      Eastern Virginia Medical School
      Norfolk, VA
       


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

      The following faculty/staff members have the following financial relationships with commercial interests:

      Francis S. Mah, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, Eyenovia, Glaukos, iView, Johnson & Johnson Vision, Nevakar, Novartis, Ocular Science, and RxSight. 

      Sumitra Khandelwal, MD, has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Alcon Vision, Bausch + Lomb, Carl Zeiss Meditec, Dompé, Novartis, and Ocular Therapeutix.

      Marjan Farid, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Bausch + Lomb, BioTissue, Carl Zeiss Meditec, CorneaGen, Dompé, Tarsus, Orasis, Johnson & Johnson Vision, Kala Pharmaceuticals, Novartis, and Sun Pharmaceutical Industries.

      Elizabeth Yeu, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Avedro, Bausch + Lomb, BioTissue, Beaver Visitec, BlephEx, Bruder, CorneaGen, Dompé, Expert Opinion, EyePoint Pharmaceuticals, Guidepoint, Johnson & Johnson Vision, Kala Pharmaceuticals, LENSAE, Merck, Mynosys, Novartis, Ocular Science, Ocular Therapeutix, Ocusoft, Omeros, Oyster Point Pharma, Science Based Health, Shire, Sight Sciences, Sun Pharma, Surface, Thea, Tarsus, TopCon, TearLab, Visus Therapeutics, and Zeiss. Grant/Research Support: Alcon Vision, BioTissue, Ocular Science, TopCon, and TearLab. Stock/Shareholder: BlephEx, CorneaGen, Melt, Ocular Science, Oyster Point Pharma, and Tarsus.

      The Evolve staff and planners have no financial relationships with commercial interests.
      Mark Goerlitz-Jessen, MD, peer reviewer, has no financial relationships with commercial interests.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Dompé.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio

    Loading...

    00:00
    00:00
      Register

      We're glad to see you're enjoying Evolve Medical Education…
      but how about a more personalized experience?

      Register for free